Annet Kirabo D.V.M., M.Sc., Ph.D., F.A.H.A.
annetkiraboc1.bsky.social
Professor @VanderbiltHealth #Hypertension, #kidney, #immunology #HostMicrobiotaInteraction. Mother of 2, wife. Associate Editor @CircRes
👤 Joined on 16 November 2024
8544
Followers
5543
Following
52
Total Posts
📜 Kullanıcı Geçmişi
- 16 Kas 2024, 03:11
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@annetkiraboc1.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Annet Kirabo named “Top Scholar” in hypertension news.vumc.org/2025/12/23/a...
Show Post
In addition, our pivotal Phase 3 Launch-HTN trial was featured in the “Best of the Journal of the American Medical Association (JAMA) and the New England Journal of Medicine (NEJM)” session. @asnkidney.bsky.social @jama.com #Hypertension #CKD #CardioRenalMetabolic #NephSky #CardioSky
Show PostWe shared data from the P2 Explore-CKD trial during a late-breaking oral presentation at #KidneyWk. The parallel reductions in systolic blood pressure & albuminuria underscore lorundrostat's potential to improve cardio-renal outcomes in this high-risk population. ir.mineralystx.com/news-events/...
Show PostOur P3 Launch-HTN trial of lorundrostat - the largest trial of an aldosterone synthase inhibitor conducted among participants with uncontrolled or treatment-resistant hypertension - was featured in JAMA’s inaugural “Research of the Year” article! ir.mineralystx.com/news-events/... #JAMAROTY25
Show Post